110 related articles for article (PubMed ID: 3168309)
1. Circulation of a fragment of haemoglobin alpha-chain during a pentagastrin-induced flush in patients with metastatic carcinoid tumours.
Balks HJ; Thim L; Conlon JM
Clin Endocrinol (Oxf); 1988 Mar; 28(3):261-9. PubMed ID: 3168309
[TBL] [Abstract][Full Text] [Related]
2. Circulating bradykinin-like immunoreactivity and the pentagastrin-induced carcinoid flush.
Balks HJ; Conlon JM; Creutzfeldt W; Stöckmann F
Clin Endocrinol (Oxf); 1988 Aug; 29(2):141-51. PubMed ID: 3248356
[TBL] [Abstract][Full Text] [Related]
3. Serotonin release into blood after food and pentagastrin. Studies in healthy subjects and in patients with metastatic carcinoid tumors.
Richter G; Stöckmann F; Conlon JM; Creutzfeldt W
Gastroenterology; 1986 Sep; 91(3):612-8. PubMed ID: 2426155
[TBL] [Abstract][Full Text] [Related]
4. Effect of a long-acting somatostatin analogue (octreotide) on circulating tachykinins and the pentagastrin-induced carcinoid flush.
Balks HJ; Conlon JM; Creutzfeldt W; Stöckmann F
Eur J Clin Pharmacol; 1989; 36(2):133-7. PubMed ID: 2470592
[TBL] [Abstract][Full Text] [Related]
5. The effects of octreotide on basal and stimulated hormone levels in patients with carcinoid syndrome.
Oberg K; Norheim I; Theodorsson E; Ahlman H; Lundqvist G; Wide L
J Clin Endocrinol Metab; 1989 Apr; 68(4):796-800. PubMed ID: 2466045
[TBL] [Abstract][Full Text] [Related]
6. Tachykinins in carcinoid tumors: their use as a tumor marker and possible role in the carcinoid flush.
Norheim I; Theodorsson-Norheim E; Brodin E; Oberg K
J Clin Endocrinol Metab; 1986 Sep; 63(3):605-12. PubMed ID: 2426299
[TBL] [Abstract][Full Text] [Related]
7. The pentagastrin test in the diagnosis of the carcinoid syndrome. Blockade of gastrointestinal symptoms by ketanserin.
Ahlman H; Dahlström A; Grönstad K; Tisell LE; Oberg K; Zinner MJ; Jaffe BM
Ann Surg; 1985 Jan; 201(1):81-6. PubMed ID: 2578277
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin, gastrointestinal peptides, and the carcinoid syndrome.
Long RG; Peters JR; Bloom SR; Brown MR; Vale W; Rivier JE; Grahame-Smith DG
Gut; 1981 Jul; 22(7):549-53. PubMed ID: 6114901
[TBL] [Abstract][Full Text] [Related]
9. Plasma substance-P in neuroendocrine tumors and idiopathic flushing: the value of pentagastrin stimulation tests and the effects of somatostatin analog.
Vinik AI; Gonin J; England BG; Jackson T; McLeod MK; Cho K
J Clin Endocrinol Metab; 1990 Jun; 70(6):1702-9. PubMed ID: 1693375
[TBL] [Abstract][Full Text] [Related]
10. Serotonin, catecholamines, and spontaneous midgut carcinoid flush: plasma studies from flushing and nonflushing sites.
Matuchansky C; Launay JM
Gastroenterology; 1995 Mar; 108(3):743-51. PubMed ID: 7533112
[TBL] [Abstract][Full Text] [Related]
11. Bradykinin in carcinoid syndrome.
Gustafsen J; Boesby S; Nielsen F; Giese J
Gut; 1987 Nov; 28(11):1417-9. PubMed ID: 3428666
[TBL] [Abstract][Full Text] [Related]
12. Histamine in carcinoid syndrome.
Gustafsen J; Boesby S; Man WK
Agents Actions; 1988 Aug; 25(1-2):1-3. PubMed ID: 3189038
[TBL] [Abstract][Full Text] [Related]
13. Histamine release from a gastric carcinoid: provocation by pentagastrin and inhibition by somatostatin.
Roberts LJ; Bloomgarden ZT; Marney SR; Rabin D; Oates JA
Gastroenterology; 1983 Feb; 84(2):272-5. PubMed ID: 6184258
[TBL] [Abstract][Full Text] [Related]
14. Flush symptoms caused by a mesenteric carcinoid without liver metastases.
Sonnet S; Wiesner W
JBR-BTR; 2002; 85(5):254-6. PubMed ID: 12463502
[TBL] [Abstract][Full Text] [Related]
15. The pentagastrin test in the diagnosis of the carcinoid syndrome.
Ahlman H; Dahlström A; Grönstad K; Jaffe BM; Nilsson O; Oberg K
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S86-8. PubMed ID: 2412067
[TBL] [Abstract][Full Text] [Related]
16. Glucagon precipitation of carcinoid flush.
Lebovics E; Rosenthal WS
Gastrointest Endosc; 1991; 37(2):212-3. PubMed ID: 2032620
[No Abstract] [Full Text] [Related]
17. What is the cause of the carcinoid flush?
Grahame-Smith DG
Gut; 1987 Nov; 28(11):1413-6. PubMed ID: 3428665
[No Abstract] [Full Text] [Related]
18. Vasoactive peptides and the carcinoid syndrome.
Goadsby PJ; Edvinsson L; Haber PS
Ann Intern Med; 1988 Jun; 108(6):904. PubMed ID: 2453131
[No Abstract] [Full Text] [Related]
19. [Pronounced flush symptoms in carcinoid syndrome without liver metastases].
Roth J; Raschka C; Hammar CH
Leber Magen Darm; 1994 Nov; 24(6):259-61. PubMed ID: 7531269
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide K-(1-24)-peptide: storage and release by carcinoid tumors.
Conlon JM; Deacon CF; Grimelius L; Cedermark B; Murphy RF; Thim L; Creutzfeldt W
Peptides; 1988; 9(4):859-66. PubMed ID: 3226960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
